Rogers Announces Nomination of Dr. Larry Berger as Independent Director at 2023 Annual Meeting of Shareholders Mar 15, 2023 04:05PM
Rogers (ROG) Announces Agreement with Starboard Value Feb 27, 2023 06:50AM
Rogers Announces Agreement with Starboard Value Feb 27, 2023 06:50AM
Rogers (ROG) to Cut 7% of Staff, Announces Additional Actions to Streamline Operations Feb 16, 2023 06:57AM
Rogers Announces Additional Actions to Streamline Operations and Increase Operating Margin Feb 16, 2023 06:55AM


Jan 20, 2023 10:32AM Rogers Appoints Senior Vice President of Global Operations and Supply Chain
Nov 17, 2022 04:18PM Rogers (ROG) Announces CEO Retirement, Appoints Colin Gouveia as Successor
Nov 17, 2022 04:15PM Rogers Announces Leadership Transition
Nov 2, 2022 04:26PM Rogers (ROG) Announces Termination of Merger Agreement with DuPont, Receives $162.5M Fee
Nov 2, 2022 04:25PM Rogers Announces Termination of Merger Agreement with DuPont
Nov 2, 2022 06:01AM Rogers (ROG) Responds to DuPont’s Notice of Termination of Merger Agreement
Nov 2, 2022 06:00AM Rogers Issues Statement Regarding DuPont’s Notice of Termination of Merger Agreement
Mar 21, 2018 03:37AM GlaxoSmithKline prescribes commercial reboot for pharma division